The Cancer API Market has experienced remarkable growth in recent years, driven by escalating global cancer burden, expanding pipeline of targeted therapies and immunooncology agents, and increasing outsourcing of active pharmaceutical ingredient manufacturing by pharmaceutical and biotechnology companies. These highly specialized chemical and biological substances serve as the...